CD36 and metabolic dysfunction-associated steatohepatitis: Hence, the combination of increased fatty acid uptake with decreased fatty acid oxidation upon CD36 hyper-palmitoylation inevitably results in massive steatosis in the liver, contributing to the development of NASH.